Search research articles
Contact Us
Filters
Showing results (141-150 of 220) with videos related to
Page
of 22
Sort By:
The Journal of Clinical Psychiatry
|
November 26, 2002
Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study
Pierre-Michel Llorca, Christian Spadone, Olivier Sol, et al.
Plos One
|
September 8, 2021
Can empathy be taught? A cross-sectional survey assessing training to deliver the diagnosis of end stage renal disease
Alice Doreille, Eve Vilaine, Xavier Belenfant, et al.
Frontiers in Cellular Neuroscience
|
September 2, 2017
Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression
Indira Mendez-David, Céline Boursier, Valérie Domergue, et al.
Pain Medicine (Malden, Mass.)
|
December 19, 2014
Do male and female general practitioners differently prescribe chronic pain drugs to older patients?
Aida Lazkani, Tiba Delespierre, Linda Benattar-Zibi, et al.
Expert Opinion on Pharmacotherapy
|
August 2, 2021
Dosing antipsychotics in special populations of patients with schizophrenia: severe psychotic agitation, first psychotic episode and elderly patients
Fayçal Mouaffak, Florian Ferreri, Julie Bourgin-Duchesnay, et al.
Translational Psychiatry
|
February 25, 2026
Applying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology
Jiayue-Clara Jiang, Camille Brianceau, Elise Delzant, et al.
Journal of Affective Disorders
|
January 2, 2019
Methemoglobinemia as a biomarker of dapsone-induced mania severity
Romain Colle, Abd El Kader Ait Tayeb, Pierre Mesdom, et al.
Basic & Clinical Pharmacology & Toxicology
|
January 7, 2020
SOD2 genetic polymorphism (rs4880) has no impact on 6-month response to antidepressant treatment and inflammatory biomarkers in depressed patients
Abd El Kader Ait Tayeb, Laurent Becquemont, Khalil El-Asmar, et al.
Pharmacogenomics
|
March 1, 2017
No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients
Eric Deflesselle, Céline Verstuyft, Anne-Cécile Petit, et al.
Psychiatry and Clinical Neurosciences
|
December 5, 2022
Habenular volume in depressed patients
Josselin Etienne, Alexandre Boutigny, Kim Tran Dong Minh Ngoc Thien, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 220) with videos related to
Sort By:
Page
of 22
The Journal of Clinical Psychiatry
|
November 26, 2002
Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study
Pierre-Michel Llorca, Christian Spadone, Olivier Sol, et al.
Plos One
|
September 8, 2021
Can empathy be taught? A cross-sectional survey assessing training to deliver the diagnosis of end stage renal disease
Alice Doreille, Eve Vilaine, Xavier Belenfant, et al.
Frontiers in Cellular Neuroscience
|
September 2, 2017
Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression
Indira Mendez-David, Céline Boursier, Valérie Domergue, et al.
Pain Medicine (Malden, Mass.)
|
December 19, 2014
Do male and female general practitioners differently prescribe chronic pain drugs to older patients?
Aida Lazkani, Tiba Delespierre, Linda Benattar-Zibi, et al.
Expert Opinion on Pharmacotherapy
|
August 2, 2021
Dosing antipsychotics in special populations of patients with schizophrenia: severe psychotic agitation, first psychotic episode and elderly patients
Fayçal Mouaffak, Florian Ferreri, Julie Bourgin-Duchesnay, et al.
Translational Psychiatry
|
February 25, 2026
Applying machine-learning and deep-learning to predict depression from brain MRI and identify depression-related brain biology
Jiayue-Clara Jiang, Camille Brianceau, Elise Delzant, et al.
Journal of Affective Disorders
|
January 2, 2019
Methemoglobinemia as a biomarker of dapsone-induced mania severity
Romain Colle, Abd El Kader Ait Tayeb, Pierre Mesdom, et al.
Basic & Clinical Pharmacology & Toxicology
|
January 7, 2020
SOD2 genetic polymorphism (rs4880) has no impact on 6-month response to antidepressant treatment and inflammatory biomarkers in depressed patients
Abd El Kader Ait Tayeb, Laurent Becquemont, Khalil El-Asmar, et al.
Pharmacogenomics
|
March 1, 2017
No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients
Eric Deflesselle, Céline Verstuyft, Anne-Cécile Petit, et al.
Psychiatry and Clinical Neurosciences
|
December 5, 2022
Habenular volume in depressed patients
Josselin Etienne, Alexandre Boutigny, Kim Tran Dong Minh Ngoc Thien, et al.
Page
of 22